PMID: 42228334

Renal or Hepatic Impairment Does Not Affect Pharmacokinetics, Safety, or Tolerability of Subcutaneous Cagrilintide.

Nielsen Mette J F, Becker Niels-Peter, Duus Helene H Hansen, Kirkeby Katrine, Kupčová Viera, Lauenborg Britt W, Low Benjamin, Svolgaard Olivia, Witten Louise

Clinical pharmacokinetics · 2026

Vol. 65, Issue 7, pp. 1087-1099

This entry links to third-party literature. For research use only.